Home MirrorEgo Technologies Secures Tens of Millions in Angel Funding to Pioneer Digital Therapeutics in China's $20B Mental Health Market

MirrorEgo Technologies Secures Tens of Millions in Angel Funding to Pioneer Digital Therapeutics in China's $20B Mental Health Market

Mar 02, 2022 15:29 CST Updated 15:29

Editor’s Note: This article is republished from Yitou, with authorization granted to VCBeat.


“Shenzhen Jingxiang Technology Co., Ltd.” recently announced the completion of its angel round of financing. The round was led by Shidai Bole, with participation from other prominent industry angel investors. TMFOX Healthcare served as the exclusive financial advisor to facilitate the financing. Jingxiang Technology is dedicated to leveraging artificial intelligence and integrating multi-dimensional recognition capabilities—including video, voice, and semantics—to innovatively develop products that create a closed-loop digital service platform for mental health screening and therapeutic intervention. The company empowers early screening, early diagnosis, and early intervention for public mental health issues, as well as big data-driven early warning and management. Currently, Jingxiang Technology’s adult mental health screening solution has obtainedNMPA Class II Medical Device Registration Certificate; business model validated across multiple application scenarios


According to official statistics, the prevalence of mental and psychological disorders has increased 160-fold over the past 20 years. With strong demand for mental health services, the market size is approaching RMB 200 billion. The target population covers K-12 schools, universities, government agencies and public institutions, small, medium, and large enterprises, nursing homes, and more, spanning nearly the entire life cycle. Driven by rising economic standards, diversified payment methods, and supportive policies, the industry is gradually entering a period of explosive growth. However, due to scarce medical resources and social stigma surrounding these conditions, consumers are more inclined to adopt self-help mental health models.


Huang Li, Founder of Shenzhen Jingxiang Technology Co., Ltd.It is stated that the rapid development of online mental health service platforms is driven by continuous technological advancements. Unlike traditional counseling, which requires scheduling and appointments, AI-based mental health applications allow users to access diagnostic and therapeutic support anytime and anywhere. Mental health professionals are predominantly concentrated in first-tier cities, leaving rural and remote areas with staff shortages and a lack of high-quality medical services. AI-based applications offer the possibility of accessing medical services at any time, with chatbots and apps available 24/7 regardless of location. MirrorTech’s independently developed mental health screening and self-help intervention products demonstrate advantages in ease of use, clinical effectiveness, service safety, and supply adequacy. Starting with self-screening, subclinical psychological issues and mild psychological problems can be addressed through AI-driven self-intervention, while intelligent crisis early-warning systems facilitate the early detection of moderate to severe psychological conditions. Currently, depression assessment and self-intervention tools are being utilized by numerous medical institutions, schools, and internet platforms. These digital therapeutics leverage multiple internationally leading, proprietary AI technologies. Collaborating partners include the University of Cambridge, the University of Hong Kong, Central China Normal University, East China Normal University, Wuhan Mental Health Center, and Shenzhen Kangning Hospital.


Yu Xiangyu, Chairman of Yitou MedicalIt has been demonstrated that AI algorithms for mental health care can successfully detect symptoms of depression, post-traumatic stress disorder (PTSD), and other conditions by analyzing behavior. Some studies indicate that these algorithms make more accurate assumptions than clinicians in distinguishing between genuine and feigned suicide risk, and they have increased the prediction rate of mental illness among at-risk adolescents to 100%. AI-based therapists make it easier for individuals to open up when sharing embarrassing experiences. This is particularly important for those who feel uncomfortable in face-to-face interactions due to shame or fear of judgment. Mirror Image Technology Co., Ltd. boasts an excellent entrepreneurial team, a competitive product R&D pipeline, and a clear development roadmap. Currently, its consumer-facing (C-end) AI assessment software achieves a specificity of 88% and an intervention success rate of over 90%. Within two years of its establishment, the company has filed eight internationally leading self-developed invention patents and obtained one Class II medical device certification. It is also strategically positioning itself to secure more complex Class III certifications based on evidence-based medicine, standing out as a leader among startups.


About Yitou Lab


Yi Tou Lab is a research-oriented accelerator established by TMFOX, China’s first virtual incubator operator, leveraging its professional expertise in collaboration with academic research experts. Focusing on chronic diseases, mental health, and smart portable medical devices, Yi Tou Lab empowers domestic and international startup teams in these fields through academic and applied technology research projects. It assists them in product design, clinical and regulatory approval simulations, and small-batch production, thereby accelerating the translation of scientific achievements and the commercialization of core technologies.


About Yitou


Yitou is a boutique investment bank focused on the healthcare and medical industry. We are committed to enhancing quality of life through continuous innovation and investment practices. Founded in Shenzhen, China’s cradle of high-tech innovation, Yitou has expanded its business network globally since its inception in 2009. We remain deeply rooted in our clients’ growth strategies, financing, product innovation, and R&D, leveraging our industry insights and comprehensive solutions to drive their success. In China, our service network spans every city in the Guangdong-Hong Kong-Macao Greater Bay Area, including Shenzhen, Dongguan, Huizhou, Zhongshan, and Guangzhou. Additionally, we maintain offices and professional teams in Vancouver, Seattle, and Boston in North America.